Literature DB >> 21846182

Prognosis of patients with t(8;16)(p11;p13) acute myeloid leukemia.

Tanya Brown, John Swansbury, Mary M Taj.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21846182     DOI： 10.3109/10428194.2011.614703

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  10 in total

1.  Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain Inhibitor.

Authors:  Wylie S Palmer; Guillaume Poncet-Montange; Gang Liu; Alessia Petrocchi; Naphtali Reyna; Govindan Subramanian; Jay Theroff; Anne Yau; Maria Kost-Alimova; Jennifer P Bardenhagen; Elisabetta Leo; Hannah E Shepard; Trang N Tieu; Xi Shi; Yanai Zhan; Shuping Zhao; Michelle C Barton; Giulio Draetta; Carlo Toniatti; Philip Jones; Mary Geck Do; Jannik N Andersen
Journal:  J Med Chem       Date:  2015-07-06       Impact factor: 7.446

Review 2.  Biological function and histone recognition of family IV bromodomain-containing proteins.

Authors:  Jonathan T Lloyd; Karen C Glass
Journal:  J Cell Physiol       Date:  2017-06-13       Impact factor: 6.384

Review 3.  The MOZ histone acetyltransferase in epigenetic signaling and disease.

Authors:  Samuel Carlson; Karen C Glass
Journal:  J Cell Physiol       Date:  2014-11       Impact factor: 6.384

4.  Molecular insights into the recognition of N-terminal histone modifications by the BRPF1 bromodomain.

Authors:  Amanda Poplawski; Kaifeng Hu; Woonghee Lee; Senthil Natesan; Danni Peng; Samuel Carlson; Xiaobing Shi; Stefan Balaz; John L Markley; Karen C Glass
Journal:  J Mol Biol       Date:  2013-12-12       Impact factor: 5.469

5.  Two rare cases of acute myeloid leukemia with t(8;16)(p11.2;p13.3) and 1q duplication: case presentation and literature review.

Authors:  Meng Liu; Yuan Ren; Xianfu Wang; Xianglan Lu; Ming Li; Young Mi Kim; Shibo Li; Lijun Zhang
Journal:  Mol Cytogenet       Date:  2020-08-25       Impact factor: 2.009

6.  A rare der(Y)t(Y;1)(q12;q12) in a patient with post-polycythemic myelofibrosis: a case report.

Authors:  Masahiro Manabe; Osami Takeda; Junya Okita; Teruhito Takakuwa; Naonori Harada; Hirofumi Nakano; Shuichiro Okamoto; Yasutaka Aoyama; Takeo Kumura; Tadanobu Ohta; Yoshio Furukawa; Atsuko Mugitani
Journal:  Am J Blood Res       Date:  2013-05-05

7.  Structural insights into recognition of acetylated histone ligands by the BRPF1 bromodomain.

Authors:  Mulu Y Lubula; Brian E Eckenroth; Samuel Carlson; Amanda Poplawski; Maksymilian Chruszcz; Karen C Glass
Journal:  FEBS Lett       Date:  2014-09-30       Impact factor: 4.124

8.  Crystallization and preliminary X-ray diffraction analysis of the BRPF1 bromodomain in complex with its H2AK5ac and H4K12ac histone-peptide ligands.

Authors:  Mulu Y Lubula; Amanda Poplawaski; Karen C Glass
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-09-25       Impact factor: 1.056

9.  Comparison between karyotyping-FISH-reverse transcription PCR and RNA-sequencing-fusion gene identification programs in the detection of KAT6A-CREBBP in acute myeloid leukemia.

Authors:  Ioannis Panagopoulos; Synne Torkildsen; Ludmila Gorunova; Anne Tierens; Geir E Tjønnfjord; Sverre Heim
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

Review 10.  Chemical probes and inhibitors of bromodomains outside the BET family.

Authors:  Moses Moustakim; Peter G K Clark; Duncan A Hay; Darren J Dixon; Paul E Brennan
Journal:  Medchemcomm       Date:  2016-09-07       Impact factor: 3.597
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.